PhRMA's SVP says newspaper overlooks benefit of DTC

Share this content:
PhRMA SVP Ken Johnson, responding to a Christian Science Monitor piece critical of drug DTC advertising, said the newspaper "unfortunately overlooks the educational benefits of direct-to-consumer advertising of prescription medicines."
Share this content:
Scroll down to see the next article